A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
Su Jong Yu
Clin Mol Hepatol. 2016;22(1):7-17. Published online 2016 Mar 28 DOI: https://doi.org/10.3350/cmh.2016.22.1.7
|
Citations to this article as recorded by
Robotic versus laparoscopic liver resection for liver malignancy: a systematic review and meta-analysis of propensity score-matched studies
Zhang-tao Long, Hua-jian Li, Hao Liang, Ya-chen Wu, Sajid Ameer, Xi-lin Qu, Zhi-qiang Xiang, Qian Wang, Xiao-ming Dai, Zhu Zhu
Surgical Endoscopy.2024; 38(1): 56. CrossRef Synergistic Effects of Nanoscale CaO2 Combined with PD-1 Inhibitors in the Treatment of Hepatocellular Carcinoma: A Promising Combination
Yingliang Wang, Shuguang Ju, Huimin Zhou, Yaowei Bai, Chen Zhou, Jiacheng Liu, Xiangjun Dong, Chuansheng Zheng
International Journal of Nanomedicine.2024; Volume 19: 137. CrossRef A Retrospective Cohort Analysis of Transarterial Chemoembolization for Hepatocellular Cancer at a Tertiary Center in Switzerland
Fabian Haak, Tobias Karli, Martin Takes, Christoph J. Zech, Otto Kollmar, Savas D. Soysal
Journal of Clinical Medicine.2024; 13(11): 3279. CrossRef Acoustic-holography-patterned primary hepatocytes possess liver functions
Changcan Li, Gang Xu, Yinhan Wang, Laixin Huang, Feiyan Cai, Long Meng, Bao Jin, Zhuoran Jiang, Hang Sun, Haitao Zhao, Xin Lu, Xingting Sang, Pengyu Huang, Fei Li, Huayu Yang, Yilei Mao, Hairong Zheng
Biomaterials.2024; 311: 122691. CrossRef Bioprinting of hepatic tissue using 3D technology: Transitioning beyond laboratory models to real-world applications in medical treatments
Suraj Kumar, Rishabha Malviya
Applied Materials Today.2024; 39: 102307. CrossRef Impact of pre-sarcopenia on outcomes of transarterial chemoembolization in unresectable hepatocellular carcinoma
Attapon Rattanasupar, Tanaporn Prateepchaiboon, Keerati Akarapatima, Apiradee Songjamrat, Songklod Pakdeejit, Arunchai Chang
Scientific Reports.2024;[Epub] CrossRef Diffuse infiltrative hepatocellular carcinoma: Multimodality imaging manifestations
Seyedeh Panid Madani, Mohammad Mirza‐Aghazadeh‐Attari, Alireza Mohseni, Timothy Pawlik, Ihab R. Kamel
Journal of Surgical Oncology.2023; 127(3): 385. CrossRef Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals
Ginny Jacobs, Deborah A. Boyle, Hashem B. El‐Serag, Robert J. Lewandowski, Stacey M. Stein, Patrice Lazure, Pam McFadden
Cancer Medicine.2023; 12(3): 3670. CrossRef Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies
Sven H. Loosen, Markus S. Jördens, Berenike Schoon, Gerald Antoch, Tom Luedde, Peter Minko, Christina Loberg, Christoph Roderburg
Journal of Cancer Research and Clinical Oncology.2023; 149(9): 6181. CrossRef Longitudinal ultrasound imaging and network modeling in rats reveal sex-dependent suppression of liver regeneration after resection in alcoholic liver disease
Benjamin K. Barnhart, Toshiki Kan, Ankita Srivastava, Corinne E. Wessner, John Waters, Manju Ambelil, John R. Eisenbrey, Jan B. Hoek, Rajanikanth Vadigepalli
Frontiers in Physiology.2023;[Epub] CrossRef Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
Su Jong Yu, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Hyo-Cheol Kim, Jin Wook Chung, Jung-Hwan Yoon, Yoon Jun Kim
Journal of Liver Cancer.2023; 23(1): 166. CrossRef Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma
Nozipho Nyakale, Luca Filippi, Colleen Aldous, Mike Sathekge
Cancers.2023; 15(7): 1975. CrossRef Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib
Jung Woo Eun, Jung Hwan Yoon, Hye Ri Ahn, Seokhwi Kim, Young Bae Kim, Su Bin Lim, Won Park, Tae Wook Kang, Geum Ok Baek, Moon Gyeong Yoon, Ju A Son, Ji Hyang Weon, Soon Sun Kim, Hyo Jung Cho, Jae Youn Cheong
Cancer Communications.2023; 43(4): 455. CrossRef C4orf47 is a Novel Prognostic Biomarker and Correlates with Infiltrating Immune Cells in Hepatocellular Carcinoma
Hye-Ran Kim, Choong Won Seo, Sang Jun Han, Jongwan Kim
Biomedical Science Letters.2023; 29(1): 11. CrossRef Progress in bioprinting technology for tissue regeneration
Alireza Sabzevari, Hossein Rayat Pisheh, Mojtaba Ansari, Amir Salati
Journal of Artificial Organs.2023; 26(4): 255. CrossRef A Comprehensive Narrative Review on the History, Current Landscape, and Future Directions of Hepatocellular Carcinoma (HCC) Systemic Therapy
Alexander Lazzaro, Kevan L. Hartshorn
Cancers.2023; 15(9): 2506. CrossRef Efficacy of fusion imaging for immediate post‐ablation assessment of malignant liver neoplasms: A systematic review
Pragati Rai, Mohammed Yusuf Ansari, Mohammed Warfa, Hammad Al‐Hamar, Julien Abinahed, Ali Barah, Sarada Prasad Dakua, Shidin Balakrishnan
Cancer Medicine.2023; 12(13): 14225. CrossRef Predicting the prognosis of liver cancer patients based on cell differentiation trajectory and application of nanomaterials in treatment
Ximei XU, Zhikun ZHANG, Qiaoying CHEN, Tao WU, Wei SHI, Lu GAN, Xiuli LIU, Runzhe LIU, Yong HUANG, Ruirui ZHANG, Yongxiang ZHAO, Pan WU, Liping ZHONG, Jian HE
Minerva Surgery.2023;[Epub] CrossRef Chest wall mass as a sign of ignored hepatocellular carcinoma in an alcoholic cirrhotic patient: a case report
Elisha Poddar, Suraj Shrestha, Raju Thapa, Sudhan Subedi, Niharika Pathak, Ramesh Khadayat, Pradeep Regmi
Annals of Medicine & Surgery.2023; 85(8): 4092. CrossRef Feasibility of combination of Gun-Chil-Jung and cytokine-induced killer cells-based immunotherapy for terminal hepatocellular carcinoma patient: a case report
Chan-Ran Park, Hye-Ri Bae, Ga-Young Lee, Chang-Gue Son, Jung-Hyo Cho, Chong-Kwan Cho, Nam-Hun Lee
Frontiers in Pharmacology.2023;[Epub] CrossRef Levels of PIVKA-II and alpha-fetoprotein in unresectable hepatocellular carcinoma compared to healthy controls and predictive values of both markers with radiological responses after loco-regional interventions
Norhanan Hamzah, Nur Karyatee Kassim, Julia Omar, Mohd Shafie Abdullah, Yeong Yeh Lee
PeerJ.2023; 11: e15988. CrossRef Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance
Saein Kim, Sunghwan Yoo, Jung Il Lee, Sora Kim, Hye Young Chang, Dokyun Kim, Seok Hoon Jeong, Kwan Sik Lee, Hyun Woong Lee
Digestive Diseases and Sciences.2022; 67(1): 321. CrossRef Outcomes of robotic‐assisted liver surgery versus laparoscopic liver surgery for treatment of stage I hepatocellular carcinoma
Linh M. Duong, Hui Cai, Martha J. Shrubsole, Christina E. Bailey, Kamran Idrees, Xiao‐Ou Shu
Cancer.2022; 128(4): 762. CrossRef Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression
Shoujin Cao, Yinghua Zou, Tianshi Lyu, Zeyang Fan, Haitao Guan, Li Song, Xiaoqiang Tong, Jian Wang
International Journal of Hyperthermia.2022; 39(1): 1. CrossRef Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma
Guorong Jia, Juno Van Valkenburgh, Austin Z. Chen, Quan Chen, Jindian Li, Changjing Zuo, Kai Chen
WIREs Nanomedicine and Nanobiotechnology.2022;[Epub] CrossRef Leveraging deep phenotyping from health check-up cohort with 10,000 Korean individuals for phenome-wide association study of 136 traits
Eun Kyung Choe, Manu Shivakumar, Anurag Verma, Shefali Setia Verma, Seung Ho Choi, Joo Sung Kim, Dokyoon Kim
Scientific Reports.2022;[Epub] CrossRef Establishment of a Novel Mouse Hepatocellular Carcinoma Model for Dynamic Monitoring of Tumor Development by Bioluminescence Imaging
Xiangyi Cao, Yulong Zhang, Qianqian Zhou, Sujing Sun, Minwei He, Xiaohui Wang, Ping Ma, Xiaoang Yang, Liping Lv, Linsheng Zhan
Frontiers in Oncology.2022;[Epub] CrossRef Surgical Resection Is Preferred in Selected Solitary Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
Jaehun Yang, Jong Man Kim, Jinsoo Rhu, Gyu-Seong Choi, Choon Hyuck David Kwon, Jae-Won Joh
Digestive Surgery.2022; 39(1): 42. CrossRef Validation for models for tumor recurrence after liver transplantation in hepatectomy patients
Sung Joon Kim, Jong Man Kim, Nam-Joon Yi, Gyu-Seong Choi, Kwang-Woong Lee, Kyung-Suk Suh, Jae-Won Joh
Annals of Surgical Treatment and Research.2022; 102(3): 131. CrossRef Practical utility of liver segmentation methods in clinical surgeries and interventions
Mohammed Yusuf Ansari, Alhusain Abdalla, Mohammed Yaqoob Ansari, Mohammed Ishaq Ansari, Byanne Malluhi, Snigdha Mohanty, Subhashree Mishra, Sudhansu Sekhar Singh, Julien Abinahed, Abdulla Al-Ansari, Shidin Balakrishnan, Sarada Prasad Dakua
BMC Medical Imaging.2022;[Epub] CrossRef Medical Treatment for Hepatocellular Carcinoma in Japan
Youichi Kawano, Yohei Kaneya, Yuto Aoki, Masato Yoshioka, Akira Matsushita, Tetsuya Shimizu, Junji Ueda, Hideyuki Takata, Nobuhiko Taniai, Tomohiro Kanda, Atsushi Hirakata, Hideyuki Suzuki, Hiroshi Yoshida
Journal of Nippon Medical School.2022; 89(2): 154. CrossRef Optimal imaging criteria and modality to determine Milan criteria for the prediction of post-transplant HCC recurrence after locoregional treatment
Nieun Seo, Dong Jin Joo, Mi-Suk Park, Seung-seob Kim, Hye Jung Shin, Yong Eun Chung, Jin-Young Choi, Myoung Soo Kim, Myeong-Jin Kim
European Radiology.2022; 33(1): 501. CrossRef Intraarterial Therapies for the Management of Hepatocellular Carcinoma
Tushar Garg, Apurva Shrigiriwar, Peiman Habibollahi, Mircea Cristescu, Robert P. Liddell, Julius Chapiro, Peter Inglis, Juan C. Camacho, Nariman Nezami
Cancers.2022; 14(14): 3351. CrossRef Dickkopf-Related Protein 1 as Response Marker for Transarterial Chemoembolization of Hepatocellular Carcinomas
Anne Olbrich, Olga Gros, Sebastian Ebel, Timm Denecke, Holger Gößmann, Nicolas Linder, Florian Lordick, Dirk Forstmeyer, Daniel Seehofer, Robert Sucher, Sebastian Rademacher, Johannes Niemeyer, Madlen Matz-Soja, Thomas Berg, Florian van Bömmel
Cancers.2022; 14(19): 4807. CrossRef Impact and the delivery of loco-regional treatment for hepatocellular carcinoma during the COVID-19 pandemic
Guo Yuan How, Uei Pua
Journal of Interventional Medicine.2022; 5(4): 180. CrossRef Nanoscale CaO2 materials for synergistic transarterial chemoembolization in a VX2 orthotopic rabbit liver cancer model
Yingliang Wang, Xuelian He, Chen Zhou, Yaowei Bai, Tongqiang Li, Jiacheng Liu, Shuguang Ju, Chaoyang Wang, Guangya Xiang, Bin Xiong
Acta Biomaterialia.2022; 154: 536. CrossRef Identification of lncRNA biomarkers in hepatocellular carcinoma by comprehensive analysis of the lncRNA-mediated ceRNA network
Dingde Ye, Yaping Liu, Yanuo Chen, Guoqiang Li, Beicheng Sun, Jin Peng, Qingxiang Xu
Frontiers in Genetics.2022;[Epub] CrossRef Contrast-Enhanced Ultrasound Tumor Therapy With Abdominal Imaging Transducer
Ryan G. Morrison, Mrigendra B. Karmacharya, Chandra M. Sehgal
Journal of Medical Devices.2022;[Epub] CrossRef Cancer Progression Mediated by CAFs Relating to HCC and Identification of Genetic Characteristics Influencing Prognosis
Li Song, Qiankun Li, Yao Lu, Xianqi Feng, Rungong Yang, Shouguo Wang, Muhammad Muddassir Ali
Journal of Oncology.2022; 2022: 1. CrossRef Role of PIVKA-II in screening for malignancies at a hepatobiliary and pancreatic disease center: A large-scale real-world study
Chenghao Ge, Mingjie Luo, Kaiyuan Guo, Dong Zhu, Ning Han, Tengjiao Wang, Xiuying Zhao
iLIVER.2022; 1(4): 209. CrossRef SAMD13 as a Novel Prognostic Biomarker and its Correlation with Infiltrating Immune Cells in Hepatocellular Carcinoma
Hye-Ran Kim, Choong Won Seo, Jae-Ho Lee, Sang Jun Han, Jongwan Kim
Biomedical Science Letters.2022; 28(4): 260. CrossRef LI-RADS and transplantation: challenges and controversies
Guilherme M. Cunha, Dorathy E. Tamayo-Murillo, Kathryn J. Fowler
Abdominal Radiology.2021; 46(1): 29. CrossRef SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study)
Ryan D. Hirsch, Chris Mills, Rohit Sawhney, Siddharth Sood, Virginia Bird, Gauri Mishra, Anouk Dev, William Kemp, John Lubel, Stuart K. Roberts, Paul Gow, Amanda J. Nicoll
Journal of Gastrointestinal Cancer.2021; 52(3): 907. CrossRef Hepatocellular carcinoma and other complications of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A structured review of published works
Yuichiro Eguchi, Gabriel Wong, I‐Heng Lee, Omar Akhtar, Ricardo Lopes, Yoshio Sumida
Hepatology Research.2021; 51(1): 19. CrossRef Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
Jae Seung Lee, Young Eun Chon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Wonseok Kang, Moon Seok Choi, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Hwi Young Kim, Tae Hun Kim, Kwon Yoo,
Yonsei Medical Journal.2021; 62(1): 12. CrossRef Prognostic Value of Metabolic Imaging Data of 11C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma
Matteo Donadon, Egesta Lopci, Jacopo Galvanin, Simone Giudici, Daniele Del Fabbro, Ezio Lanza, Vittorio Pedicini, Arturo Chiti, Guido Torzilli
Cancers.2021; 13(3): 472. CrossRef Survival in untreated hepatocellular carcinoma: A national cohort study
Young Ae Kim, Danbee Kang, Hyeyoung Moon, Donghyun Sinn, Minwoong Kang, Sang Myung Woo, Yoon Jung Chang, Boram Park, Sun-Young Kong, Eliseo Guallar, Soo-Yong Shin, Geunyeon Gwak, Joung Hwan Back, Eun Sook Lee, Juhee Cho, Gianfranco D. Alpini
PLOS ONE.2021; 16(2): e0246143. CrossRef Hyperspectral image-based analysis of thermal damage for ex-vivo bovine liver utilizing radiofrequency ablation
Mohamed Hisham Aref, Ibrahim H. Aboughaleb, Abou-Bakr M. Youssef, Yasser H. El-Sharkawy
Surgical Oncology.2021; 38: 101564. CrossRef Taurine Upregulates miRNA-122-5p Expression and Suppresses the Metabolizing Enzymes of Glycolytic Pathway in Hepatocellular Carcinoma
Asmaa Abdel Nabi, Shimaa Attia Atta, Eman El-Ahwany, Emad Elzayat, Hanan Saleh
Molecular Biology Reports.2021; 48(7): 5549. CrossRef Operator Evaluation of Ultrasound Fusion Imaging Usefulness in the Percutaneous Ablation of Hepatic Malignancies: A Prospective Study
Alessandro Beleù, Alessandro Drudi, Alvise Giaretta, Riccardo De Robertis, Ilaria Fedrigo, Enrico Martone, Conci Simone, Chiara Bovo, Mirko D'Onofrio
Ultrasound in Medicine & Biology.2021; 47(11): 3159. CrossRef Hepatic patch by stacking patient-specific liver progenitor cell sheets formed on multiscale electrospun fibers promotes regenerative therapy for liver injury
Yohan Kim, Young Won Kim, Seung Bum Lee, Kyojin Kang, Sangtae Yoon, Dongho Choi, Suk-Hee Park, Jaemin Jeong
Biomaterials.2021; 274: 120899. CrossRef Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma
Ting Song, Li Li, Shaobo Wu, Yan Liu, Caiping Guo, Wen Wang, Lili Dai, Tong Zhang, Hao Wu, Bin Su
Frontiers in Oncology.2021;[Epub] CrossRef Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study
Jong Man Kim, Sung Yoo Cho, Jinsoo Rhu, Miyoung Jung, Jung Hyun Her, Okjae Lim, Gyu-Seong Choi, Eui-Cheol Shin, Yu-Kyeong Hwang, Jae-Won Joh
Annals of Hepato-Biliary-Pancreatic Surgery.2021; 25(2): 206. CrossRef Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway
Xue Hu, Fangzhou Jiao, Lan Zhang, Yingan Jiang
Frontiers in Pharmacology.2021;[Epub] CrossRef Impact of Tumor Burden Score on Conditional Survival after Curative‐Intent Resection for Hepatocellular Carcinoma: A Multi‐Institutional Analysis
Ahmed N. Elfadaly, Diamantis I. Tsilimigras, J. Madison Hyer, Alessandro Paro, Fabio Bagante, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfr
World Journal of Surgery.2021; 45(11): 3438. CrossRef PLGA nanoparticles containing α-fetoprotein siRNA induce apoptosis and enhance the cytotoxic effects of doxorubicin in human liver cancer cell line
Theeraphong Pho-iam, Primana Punnakitikashem, Chayapol Somboonyosdech, Sirinapa Sripinitchai, Patarabutr Masaratana, Vorapan Sirivatanauksorn, Yongyut Sirivatanauksorn, Chamaiphorn Wongwan, Kytai T. Nguyen, Chatchawan Srisawat
Biochemical and Biophysical Research Communications.2021; 553: 191. CrossRef Increased Liquefactive Necrosis Formation After Transarterial Chemoembolization Combined with Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
Yingliang Wang, Chen Zhou, Jiacheng Liu, Qin Shi, Songjiang Huang, Chongtu Yang, Tongqiang Li, Yang Chen, Bin Xiong
Cancer Management and Research.2021; Volume 13: 6935. CrossRef Decreased Expression of Arid1A Invasively Downregulates the Expression of Ribosomal Proteins in Hepatocellular Carcinoma
Jing Zhao, Weiran Xu, Yu Zhang, Xiaomin Lv, Yiran Chen, Gaoda Ju, Fang Yang, Li Lin, Xiaosong Rao, Ziwei Guo, Tao Xing, Li Li, Jun Liang
Biomarkers in Medicine.2021; 15(7): 497. CrossRef A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness
Shen-Yen Lin, Chien-Ming Chen, Bing-Shen Huang, Ying-Chieh Lai, Kuang-Tse Pan, Shi-Ming Lin, Sung-Yu Chu, Jeng-Hwei Tseng, Pierpaolo Alongi
PLOS ONE.2021; 16(3): e0249003. CrossRef Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient Analysis
Monica M. Matsumoto, Samdeep Mouli, Priyali Saxena, Ahmed Gabr, Ahsun Riaz, Laura Kulik, Daniel Ganger, Haripriya Maddur, Justin Boike, Steven Flamm, Christopher Moore, Aparna Kalyan, Kush Desai, Bartley Thornburg, Michael Abecassis, Ryan Hickey, Juan Cai
CardioVascular and Interventional Radiology.2021; 44(7): 1070. CrossRef MicroRNA signatures as predictive biomarkers in transarterial chemoembolization‐treated hepatocellular carcinoma
Manal S. Fawzy, Eman A. Toraih
Precision Medical Sciences.2021; 10(1): 4. CrossRef Heat Shock Protein Beta 1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
Shengyi Long, Fang Peng, Baohui Song, Liang Wang, Jun Chen, Bingbing Shang
International Journal of General Medicine.2021; Volume 14: 5483. CrossRef The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma
Shuangchi Liu, Zhiduan Xu, Zhuling Fang, Dengyong Zhang, Zhongqiang Qin, Longfei Fan, Jiakang Duan, Hongxiang Yin, Yigang Zhang, Qing Pang, Yi Tan
International Journal of General Medicine.2021; Volume 14: 4291. CrossRef β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation
Wenxiu Zhao, Lingxiang Jiang, Ting Fang, Fei Fang, Yingchun Liu, Ye Zhao, Yuting You, Hao Zhou, Xiaolin Su, Jiangwei Wang, Sheng Liu, Yaomin Chen, Jun Wan, Xiumei Huang
Frontiers in Oncology.2021;[Epub] CrossRef Laparoscopic Liver Resection versus Percutaneous Radiofrequency Ablation for Small Single Nodular Hepatocellular Carcinoma: Comparison of Treatment Outcomes
Dong Ho Lee, Jing Woong Kim, Jeong Min Lee, Jong Man Kim, Min Woo Lee, Hyunchul Rhim, Young Hoe Hur, Kyung-Suk Suh
Liver Cancer.2021; 10(1): 25. CrossRef Predicting Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Liver Resection for Solitary Hepatocellular Carcinoma
Jong Man Kim, Jae-Won Joh, Nam-Joon Yi, Gyu-Seong Choi, Kyunga Kim, Kwang-Woong Lee, Kyung-Suk Suh
Journal of Gastrointestinal Surgery.2020; 24(10): 2219. CrossRef Progress in 3D bioprinting technology for tissue/organ regenerative engineering
Ishita Matai, Gurvinder Kaur, Amir Seyedsalehi, Aneesah McClinton, Cato T. Laurencin
Biomaterials.2020; 226: 119536. CrossRef Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
Hye Soo Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Young Nyun Park, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi, Hyon-Suk Kim
Clinical and Molecular Hepatology.2020; 26(1): 33. CrossRef LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features
Se Woo Kim, Ijin Joo, Hyo-Cheol Kim, Su Joa Ahn, Hyo-Jin Kang, Sun Kyung Jeon, Jeong Min Lee
European Radiology.2020; 30(5): 2861. CrossRef Diagnostische und prognostische Bedeutung des α-Feto-Proteins beim hepatozellulären Karzinom
Jendrik Becker-Assmann, Mohammad H. Fard-Aghaie, Alexandros Kantas, Georgios Makridis, Tim Reese, Kim C. Wagner, Jörg Petersen, Peter Buggisch, Axel Stang, Thomas von Hahn, Karl J. Oldhafer
Der Chirurg.2020; 91(9): 769. CrossRef Effectiveness and feasibility of external beam radiotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium involvement: a multicenter trial in Korea (KROG 17-10)
Chai Hong Rim, Bae-Kwon Jeong, Tae Hyun Kim, Jin Hee Kim, Hyun-Cheol Kang, Jinsil Seong
International Journal of Radiation Biology.2020; 96(6): 759. CrossRef Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis
Sangdeok Shin, Sang Hoon Lee, Minjong Lee, Ji Hyun Kim, Wongu Lee, Hyun Woo Lee, Min Soo Park, Seungwoo Park, Tae Suk Kim, Dae Hee Choi
Medicine.2020; 99(9): e19008. CrossRef An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspective
Chai Hong Rim, Jason Cheng, Wen-Yen Huang, Tomoki Kimura, Victor Lee, Zhao-Chong Zeng, Jinsil Seong
Radiotherapy and Oncology.2020; 148: 73. CrossRef Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry
Jun Sik Yoon, Han Ah Lee, Jun Yong Park, Bo Hyun Kim, In Joon Lee, Young Eun Chon, Suk Kyun Hong, Dong Hyeon Lee, Hyun-Joo Kong, Young-Joo Won, Eunyang Kim, Jeong-Hoon Lee
Journal of Liver Cancer.2020; 20(1): 41. CrossRef Risk of adverse events in advanced hepatocellular carcinoma with immune checkpoint therapy: A systematic review and meta-analysis
Hang Yuan, Jiaxi Mao, Cong Liu, Hong Fu, Wenyuan Guo, Guoshan Ding
Clinics and Research in Hepatology and Gastroenterology.2020; 44(6): 845. CrossRef Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment
Zu‐Yau Lin, Jing‐Houng Wang, Ming‐Lun Yeh, Ching‐I Huang, Kwong‐Ming Kee, Yi‐Hao Yen, Shinn‐Cherng Chen, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Ming‐Lung Yu, Wan‐Long Chuang
The Kaohsiung Journal of Medical Sciences.2020; 36(9): 750. CrossRef Hepatocellular Carcinoma in a Patient With Hepatic Steatosis
John Romano, Erin Forster
ACG Case Reports Journal.2020; 7(5): e00378. CrossRef Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B
Jeong-Ju Yoo, Su Jong Yu, Bora Lee, Eun Ju Cho, Jeong-Hoon Lee, Sang Gyune Kim, Yoon Jun Kim, Young Seok Kim, Jung-Hwan Yoon
Gut and Liver.2020; 14(3): 377. CrossRef Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity
Wentao Jia, Lina Wang, Michel Mansur Machado
Evidence-Based Complementary and Alternative Medicine.2020;[Epub] CrossRef Conditional survival analysis of hepatocellular carcinoma
Mihir M. Shah, Benjamin I. Meyer, Kevin Rhee, Rachel E. NeMoyer, Yong Lin, Ching‐Wei D. Tzeng, Salma K. Jabbour, Timothy J. Kennedy, John L. Nosher, David A. Kooby, Shishir K. Maithel, Darren R. Carpizo
Journal of Surgical Oncology.2020; 122(4): 684. CrossRef Exosomes derived from chemically induced human hepatic progenitors inhibit oxidative stress induced cell death
Sujin Hyung, Jaemin Jeong, Kyusoon Shin, Ju Young Kim, Ji‐Hye Yim, Chan Jong Yu, Hyun Suk Jung, Kyung‐Gyun Hwang, Dongho Choi, Jong Wook Hong
Biotechnology and Bioengineering.2020; 117(9): 2658. CrossRef Tissue characterization utilizing hyperspectral imaging for liver thermal ablation
Mohamed Hisham Aref, Ibrahim H. Aboughaleb, Yasser H. El-Sharkawy
Photodiagnosis and Photodynamic Therapy.2020; 31: 101899. CrossRef Role of epigenetic alterations in aflatoxin‐induced hepatocellular carcinoma
Sathish Kumar Mungamuri, Vijay Aditya Mavuduru
Liver Cancer International.2020; 1(2): 41. CrossRef Long noncoding RNA AC092171.4 promotes hepatocellular carcinoma progression by sponging microRNA-1271 and upregulating GRB2
Chengjun Sun, Shanzhou Huang, Yuchen Hou, Zhongqiu Li, Dongmei Xia, Lishan Zhang, Yixi Zhang, Yifeng Cai, Ziming Wang, Qi Zhou, Xiaoshun He, Linwei Wu
Aging.2020; 12(14): 14141. CrossRef Comparison of Transcatheter Arterial Chemoembolization-Radiofrequency Ablation and Transcatheter Arterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma with Macrovascular Invasion Using Propensity Score Analysis: A Retrospective Cohort Stu
Yao Liu, Yuxin Li, Fangyuan Gao, Qun Zhang, Xue Yang, Bingbing Zhu, Shuaishuai Niu, Yunyi Huang, Ying Hu, Wei Li, Xianbo Wang
Journal of Oncology.2020; 2020: 1. CrossRef Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study
Anwaar Saeed, Hannah Hildebrand, Robin Park, Mohammed Al-Jumayli, Saqib Abbasi, Tina Melancon, Azhar Saeed, Raed Al-Rajabi, Anup Kasi, Joaquina Baranda, Stephen Williamson, Weijing Sun
Journal of Clinical Medicine.2020; 9(9): 2682. CrossRef Treatment patterns and direct medical costs among patients with advanced hepatocellular carcinoma
Abdalla Aly, Elisabetta Malangone-Monaco, Virginia Noxon, Caroline Henriques, Fernando Benavente, Amy Kim
Current Medical Research and Opinion.2020; 36(11): 1813. CrossRef A non-synonymous variant rs12614 of complement factor B associated with risk of chronic hepatitis B in a Korean population
Jung Yeon Seo, Joong-Gon Shin, Byeong Ju Youn, Suhg Namgoong, Hyun Sub Cheong, Lyoung Hyo Kim, Ji On Kim, Hyoung Doo Shin, Yoon Jun Kim
BMC Medical Genetics.2020;[Epub] CrossRef Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives
Daniel M. Girardi, Jana Priscila M. Pacífico, Fernanda P. L. Guedes de Amorim, Gustavo dos Santos Fernandes, Marcela C. Teixeira, Allan A. L. Pereira
Pharmaceuticals.2020; 14(1): 28. CrossRef The 7th/8th American Joint Committee on Cancer and the Modified Union for International Cancer Control Staging System for Hepatocellular Carcinoma
In-Gyu Kim, Xu-Guang Hu, Hee-Jung Wang, Bong-Wan Kim, Sung Yeon Hong, Xue-Yin Shen
Yonsei Medical Journal.2019; 60(2): 140. CrossRef Optimal criteria for hepatocellular carcinoma diagnosis using CT in patients undergoing liver transplantation
Nieun Seo, Myoung Soo Kim, Mi-Suk Park, Jin-Young Choi, Chansik An, Kyunghwa Han, Seung Up Kim, Dong Jin Joo, Myeong-Jin Kim
European Radiology.2019; 29(2): 1022. CrossRef Characteristics of Early Recurrence After Curative Liver Resection for Solitary Hepatocellular Carcinoma
Sung-Mi Jung, Jong Man Kim, Gyu-Seong Choi, Choon Hyuck David Kwon, Nam-Joon Yi, Kwang-Woong Lee, Kyung Suk Suh, Jae-Won Joh
Journal of Gastrointestinal Surgery.2019; 23(2): 304. CrossRef Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells
Yohan Kim, Kyojin Kang, Seung Bum Lee, Daekwan Seo, Sangtae Yoon, Sung Joo Kim, Kiseok Jang, Yun Kyung Jung, Kyeong Geun Lee, Valentina M. Factor, Jaemin Jeong, Dongho Choi
Journal of Hepatology.2019; 70(1): 97. CrossRef Publisher's Note
Journal of Surgical Research.2019; 233: 381. CrossRef Evaluation of early treatment response to radiotherapy for HCC using pre- and post-treatment MRI
So Hee Song, Woo Kyoung Jeong, Dongil Choi, Young Kon Kim, Hee Chul Park, Jeong Il Yu
Acta Radiologica.2019; 60(7): 826. CrossRef Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization
Min Young Baek, Jeong-Ju Yoo, Soung Won Jeong, Jae Young Jang, Yong Kwon Kim, Shin Ok Jeong, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim, Su Yeon Park
The Korean Journal of Internal Medicine.2019; 34(6): 1223. CrossRef Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma
Toshifumi Hoki, Eriko Katsuta, Li Yan, Kazuaki Takabe, Fumito Ito
Journal of Surgical Research.2019; 234: 343. CrossRef Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC
Dong Ho Lee, Jeong Min Lee, Mi Hye Yu, Bo Yun Hur, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Jung-Hwan Yoon, Yoon Jun Kim, Jeong-Hoon Lee, Su Jong Yu, Joon Koo Han
European Radiology.2019; 29(6): 3122. CrossRef Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients
Dong Hyun Sinn, Gyu-Seong Choi, Hee Chul Park, Jong Man Kim, Honsoul Kim, Kyoung Doo Song, Tae Wook Kang, Min Woo Lee, Hyunchul Rhim, Dongho Hyun, Sung Ki Cho, Sung Wook Shin, Woo Kyoung Jeong, Seong Hyun Kim, Jeong Il Yu, Sang Yun Ha, Su Jin Lee, Ho Yeon
PLOS ONE.2019; 14(1): e0210730. CrossRef Hyperprogressive Disease in Hepatocellular Carcinoma with Immune Checkpoint Inhibitor Use: A Case Series
Daniel Jiahao Wong, Joycelyn Lee, Su Pin Choo, Choon Hua Thng, Tiffany Hennedige
Immunotherapy.2019; 11(3): 167. CrossRef Reply
Young‐Sun Lee, Myung Han Hyun, Sun Young Yim, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun
Hepatology.2019; 69(2): 924. CrossRef Ceramide-Graphene Oxide Nanoparticles Enhance Cytotoxicity and Decrease HCC Xenograft Development: A Novel Approach for Targeted Cancer Therapy
Shi-Bing Wang, Ying-Yu Ma, Xiao-Yi Chen, Yuan-Yuan Zhao, Xiao-Zhou Mou
Frontiers in Pharmacology.2019;[Epub] CrossRef Future Liver Remnant Hypertrophy after Portal Vein Embolization Is Inversely Correlated with Intrahepatic Tumor Burden
Edwin A. Takahashi, Chad J. Fleming, James C. Andrews
Journal of Vascular and Interventional Radiology.2019; 30(3): 435. CrossRef Endoscopic Ultrasound for the Diagnosis and Staging of Liver Tumors
Andrew Lange, Thiruvengadam Muniraj, Harry R. Aslanian
Gastrointestinal Endoscopy Clinics of North America.2019; 29(2): 339. CrossRef Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma
Jeong-Ju Yoo, Su Jong Yu, Juri Na, Kyungmin Kim, Young Youn Cho, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Hyewon Youn, Jung-Hwan Yoon
International Journal of Molecular Sciences.2019; 20(6): 1292. CrossRef Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Young Eun Chon, Hana Park, Hye Kyung Hyun, Yeonjung Ha, Mi Na Kim, Beom Kyung Kim, Joo Ho Lee, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Seong Gyu Hwang, Kwang-Hyub Han, Kyu Sung Rim, Jun Yong Park
Cancers.2019; 11(4): 509. CrossRef Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
Mi Young Jeon, Hye Soo Kim, Tae Seop Lim, Dai Hoon Han, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Gi Hong Choi, Jin Sub Choi, Kwang-Hyub Han, Seung Up Kim, Gianfranco D. Alpini
PLOS ONE.2019; 14(4): e0214613. CrossRef Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis
Jiwoon Choi, Taek Chung, Hyungjin Rhee, Young-Joo Kim, Youngsic Jeon, Jeong Eun Yoo, Songmi Noh, Dai Hoon Han, Young Nyun Park
Gut and Liver.2019; 13(1): 83. CrossRef Intrahepatic distant recurrence after radiofrequency ablation of hepatocellular carcinoma: relationship with portal hypertension
Ran Kim, Woo Kyoung Jeong, Tae Wook Kang, Kyoung Doo Song, Min Woo Lee, Soo Hyun Ahn, Hyunchul Rhim
Acta Radiologica.2019; 60(12): 1609. CrossRef Analyses of a Panel of Transcripts Identified From a Small Sample Size and Construction of RNA Networks in Hepatocellular Carcinoma
Zhiyong Sheng, Xiaolin Wang, Geliang Xu, Ge Shan, Liang Chen
Frontiers in Genetics.2019;[Epub] CrossRef Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma
Bo Hyun Kim, Joong-Won Park, Jin Sook Kim, Sook-Kyung Lee, Eun Kyung Hong
Gut and Liver.2019; 13(3): 342. CrossRef Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
Jun Sik Yoon, Byeong Geun Song, Jeong-Hoon Lee, Hyo Young Lee, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Joon Hyeok Lee, Jung-Hwan Yoon
BMC Cancer.2019;[Epub] CrossRef Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
Thomas Yau, Chiun Hsu, Tae-You Kim, Su-Pin Choo, Yoon-Koo Kang, Ming-Mo Hou, Kazushi Numata, Winnie Yeo, Akhil Chopra, Masafumi Ikeda, Ryoko Kuromatsu, Michihisa Moriguchi, Yee Chao, Huanyu Zhao, Jeffrey Anderson, Christine Dela Cruz, Masatoshi Kudo
Journal of Hepatology.2019; 71(3): 543. CrossRef The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver disease
H. Taflin, L. Hafström, E. Holmberg, M. Castedal, P. Lindnér
Scandinavian Journal of Gastroenterology.2019; 54(6): 746. CrossRef Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis
David Sooik Kim, Tae Seop Lim, Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Oidov Baatarkhuu, Seung Up Kim
Digestive Diseases and Sciences.2019; 64(12): 3660. CrossRef Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression
Yu Young Joo, Jeong Won Jang, Sung Won Lee, Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Scientific Reports.2019;[Epub] CrossRef Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations
Won Hyeok Choe, Ki Jeong Kim, So Young Lee, Yu Min Choi, So Young Kwon, Jeong Han Kim, Bum Joon Kim
World Journal of Gastroenterology.2019; 25(33): 4985. CrossRef A Proposal for Modification of the Barcelona Clinic Liver Cancer Staging System Considering the Prognostic Implication of Performance Status
Hyo Jung Cho, Soon Sun Kim, So Young Kang, Min Jae Yang, Choong Kyun Noh, Jae Chul Hwang, Sun Gyo Lim, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Kwang Jae Lee, Jin Hong Kim, Sung Won Cho, Jae Youn Cheong
Gut and Liver.2019; 13(5): 557. CrossRef Hepatocellular carcinoma staging systems: Hong Kong liver cancer vs Barcelona clinic liver cancer in a Western population
Laura Bainy Rodrigues de Freitas, Larisse Longo, Deivid Santos, Ivana Grivicich, Mário Reis Álvares-da-Silva
World Journal of Hepatology.2019; 11(9): 689. CrossRef Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
Young Youn Cho, Young Hwan Choi, Su Jong Yu, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon
Journal of Liver Cancer.2019; 19(2): 128. CrossRef Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis
Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han, Do Young Kim
Scandinavian Journal of Gastroenterology.2019; 54(10): 1283. CrossRef Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database
Jae Seung Lee, In Rae Cho, Hye Won Lee, Mi Young Jeon, Tae Seop Lim, Oidov Baatarkhuu, Do Young Kim, Kwang-Hyub Han, Jun Yong Park
Cancer Research and Treatment.2019; 51(4): 1347. CrossRef Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies
Sven H. Loosen, Maximilian Schulze-Hagen, Philipp Bruners, Frank Tacke, Christian Trautwein, Christiane Kuhl, Tom Luedde, Christoph Roderburg
Cancers.2019; 11(10): 1503. CrossRef In Vitro Cytotoxicity Activity of Ethanolic Leaf Extract of Costus Igneus Against Hepatocellular Carcinoma (HepG2) Cells
I. Glory Josephine, K. Punnagai
Biomedical and Pharmacology Journal.2019; 12(2): 901. CrossRef Targetting an LncRNA P5848-ENO1 axis inhibits tumor growth in hepatocellular carcinoma
Xidan Zhu, Hui Yu, Baolin Li, Jing Quan, Zhangrui Zeng, Guangrong Li, Jinbo Liu
Bioscience Reports.2019;[Epub] CrossRef Interleukin‑8 promotes cell migration via CXCR1 and CXCR2 in liver cancer
Huijuan Bi, Yu Zhang, Shanshan Wang, Wenhao Fang, Wenjun He, Lina Yin, Ying Xue, Zhixiang Cheng, Minghui Yang, Jilu Shen
Oncology Letters.2019;[Epub] CrossRef Quantitative Ultrasound Spectroscopy for Differentiation of Hepatocellular Carcinoma from At-Risk and Normal Liver Parenchyma
Isabelle Durot, Rosa M.S. Sigrist, Nishita Kothary, Jarrett Rosenberg, Jürgen K. Willmann, Ahmed El Kaffas
Clinical Cancer Research.2019; 25(22): 6683. CrossRef Reply
Young‐Sun Lee, Myung Han Hyun, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun
Hepatology.2019; 70(1): 447. CrossRef The Clinical Implications of Liver Resection Margin Size in Patients with Hepatocellular Carcinoma in Terms of Positron Emission Tomography Positivity
Jae Hyun Park, Dong Hwi Kim, Sung Hoon Kim, Moon Young Kim, Soon Koo Baik, In Su Hong
World Journal of Surgery.2018; 42(5): 1514. CrossRef
18F–fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment
Pil Soo Sung, Hye Lim Park, Keungmo Yang, Seawon Hwang, Myeong Jun Song, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ie Ryung Yoo, Si Hyun Bae
European Journal of Nuclear Medicine and Molecular Imaging.2018; 45(3): 384. CrossRef Contrast-enhanced ultrasound of malignant liver lesions
Isabelle Durot, Stephanie R. Wilson, Jürgen K. Willmann
Abdominal Radiology.2018; 43(4): 819. CrossRef Novel biomarkers in hepatocellular carcinoma
Felice De Stefano, Eduardo Chacon, Lilia Turcios, Francesc Marti, Roberto Gedaly
Digestive and Liver Disease.2018; 50(11): 1115. CrossRef Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
Soon Sun Kim, Hyo Jung Cho, Ji Sun Nam, Hyun Ji Kim, Dae Ryong Kang, Je Hwan Won, Jinoo Kim, Jai Keun Kim, Jei Hee Lee, Bo Hyun Kim, Mi Young Lee, Sung Won Cho, Jae Youn Cheong
Journal of Korean Medical Science.2018;[Epub] CrossRef Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance
Chung Seop Lee, Yong Jin Jung, Soon Sun Kim, Jae Youn Cheong, Ga Ram Lee, Han Gyeol Kim, Beom Hee Kim, Jung Wha Chung, Eun Sun Jang, Sook-Hyang Jeong, Kyung Ho Lee, Jin-Wook Kim, Ferruccio Bonino
PLOS ONE.2018; 13(1): e0190261. CrossRef Temporal improvement in survival of patients with hepatocellular carcinoma in a hepatitis B virus‐endemic population
Bo Hyun Kim, Young‐Suk Lim, Eun‐Yang Kim, Hyun‐Joo Kong, Young‐Joo Won, Seungbong Han, Sohee Park, Jae Seok Hwang
Journal of Gastroenterology and Hepatology.2018; 33(2): 475. CrossRef Prolongation of liver-specific function for primary hepatocytes maintenance in 3D printed architectures
Yohan Kim, Kyojin Kang, Sangtae Yoon, Ji Sook Kim, Su A. Park, Wan Doo Kim, Seung Bum Lee, Ki-Young Ryu, Jaemin Jeong, Dongho Choi
Organogenesis.2018; 14(1): 1. CrossRef High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016
Song-Huy Nguyen-Dinh, Albert Do, Trang Ngoc Doan Pham, Doan Y Dao, Trinh Nhu Nguy, Moon S Chen Jr
World Journal of Hepatology.2018; 10(1): 116. CrossRef Novel Albumin–Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization
Jung Hee Kim, Dong Hyun Sinn, Jeong-Hoon Lee, Dongho Hyun, Sung Ki Cho, Sung Wook Shin, Young Chang, Yoon Jun Kim, Jung-Hwan Yoon, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi
Digestive Diseases and Sciences.2018; 63(4): 1062. CrossRef ALBI versus Child‐Pugh grading systems for liver function in patients with hepatocellular carcinoma
Seong K. Na, Sun Y. Yim, Sang J. Suh, Young K. Jung, Ji H. Kim, Yeon S. Seo, Hyung J. Yim, Jong E. Yeon, Kwan S. Byun, Soon H. Um
Journal of Surgical Oncology.2018; 117(5): 912. CrossRef Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
Ja Yoon Heo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hyon-Suk Kim, Young Nyun Park, Kwang-Hyub Han, Kijun Song, Seung Up Kim
Gut and Liver.2018; 12(2): 190. CrossRef Early disseminated recurrence after liver resection in solitary hepatocellular carcinoma
Jong Man Kim, Nam-Joon Yi, Choon Hyuck David Kwon, Kwang-Woong Lee, Kyung-Suk Suh, Jae-Won Joh
Annals of Surgical Treatment and Research.2018; 94(3): 129. CrossRef Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance
Y. E. Chon, K. S. Jung, M.‐J. Kim, J.‐Y. Choi, C. An, J. Y. Park, S. H. Ahn, B. K. Kim, S. U. Kim, H. Park, S. K. Hwang, K. S. Rim, K.‐H. Han, D. Y. Kim
Alimentary Pharmacology & Therapeutics.2018; 47(8): 1201. CrossRef Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein
Jin Hyoung Kim, Ju Hyun Shim, Hyun‐Ki Yoon, Heung‐Kyu Ko, Jong Woo Kim, Dong Il Gwon
Liver International.2018; 38(9): 1646. CrossRef Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?
Kwang Min Kim, Jiyu Kim, Dong Hyun Sinn, Hye Seung Kim, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Scandinavian Journal of Gastroenterology.2018; 53(6): 727. CrossRef Alpha-fetoprotein in pericardial, peritoneal, and pleural fluids: A body fluid matrix evaluation
William E. Owen, Joshua J.H. Hunsaker, Jonathan R. Genzen
Clinical Biochemistry.2018; 56: 109. CrossRef Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma
Yuri Jeong, Jinhong Jung, Byungchul Cho, Jungwon Kwak, Chiyoung Jeong, Jong Hoon Kim, Jin-hong Park, So Yeon Kim, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Sang Min Yoon
BMC Cancer.2018;[Epub] CrossRef Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells
Jiao Li, Dan-Dan Wu, Ji-Xiang Zhang, Jing Wang, Jing-Jing Ma, Xue Hu, Wei-Guo Dong
World Journal of Gastroenterology.2018; 24(17): 1901. CrossRef Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI Grade
Hajime Matsushima, Yuko Takami, Tomoki Ryu, Munehiro Yoshitomi, Masaki Tateishi, Yoshiyuki Wada, Hideki Saitsu
Journal of Gastrointestinal Surgery.2018; 22(7): 1230. CrossRef Hepatocellular Carcinoma: Review of Targeted and Immune Therapies
Daniel da Motta Girardi, Tatiana Strava Correa, Marcela Crosara Teixeira, Gustavo Dos Santos Fernandes
Journal of Gastrointestinal Cancer.2018; 49(3): 227. CrossRef Post-operative care of interventional therapy for 40 liver cancer patients with obstructive jaundice
De-ping Tong, Li-qin Wu, Xiao-ping Chen, Yi Li
European Journal of Cancer Care.2018; 27(4): e12858. CrossRef Percutaneous US/MRI Fusion–guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes
Kyoung Doo Song, Min Woo Lee, Hyunchul Rhim, Tae Wook Kang, Dong Ik Cha, Dong Hyun Sinn, Hyo Keun Lim
Radiology.2018; 288(3): 878. CrossRef Targeting Accuracy of Image-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Real-Life Clinical Practice: In Vivo Assessment Using Hepatic Parenchymal Changes on Gd-EOB-DTPA–Enhanced Magnetic Resonance Images
Jinhong Jung, Hojin Kim, Sang Min Yoon, Byungchul Cho, Yeon Joo Kim, Jungwon Kwak, Jong Hoon Kim
International Journal of Radiation Oncology*Biology*Physics.2018; 102(4): 867. CrossRef Subcentimeter Hepatocellular Carcinoma: A New Paradigm for Treatment with Percutaneous Radiofrequency Ablation?
Johannes T. Heverhagen, Slavka Kudrnová
Radiology.2018; 288(3): 887. CrossRef Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jong Hwan Choi, Woo Jin Chung, Si Hyun Bae, Do Seon Song, Myeong Jun Song, Young Seok Kim, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Jun Yong Park, Do Young Kim, Seung Up Kim, Sung Bum Cho
Cancer Chemotherapy and Pharmacology.2018; 82(3): 469. CrossRef Mitochondria-targeting nanoparticles for enhanced microwave ablation of cancer
Xiaowei Chen, Changhui Fu, Yaqin Wang, Qirun Wu, Xianwei Meng, Ke Xu
Nanoscale.2018; 10(33): 15677. CrossRef Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy
Brian E. Kouri
Techniques in Vascular and Interventional Radiology.2018; 21(4): 205. CrossRef Compensatory hypertrophy of the liver after external beam radiotherapy for primary liver cancer
Chai Hong Rim, Sangjoon Park, Joong Yeol Woo, Jinsil Seong
Strahlentherapie und Onkologie.2018; 194(11): 1017. CrossRef Hepatocellular carcinoma treatment: hurdles, advances and prospects
Ratna Kumari, Manoj Kumar Sahu, Anindita Tripathy, Kanishka Uthansingh, Manas Behera
Hepatic Oncology.2018;[Epub] CrossRef Correlation between Resection Margin and Disease Recurrence with a Restricted Cubic Spline Model in Patients with Resected Hepatocellular Carcinoma
Woohyung Lee, Ho-Seong Han, Soyeon Ahn, Yoo-Seok Yoon, Jai Young Cho, YoungRok Choi
Digestive Surgery.2018; 35(6): 520. CrossRef Evaluation of Hepatic Toxicity after Repeated Stereotactic Body Radiation Therapy for Recurrent Hepatocellular Carcinoma using Deformable Image Registration
Sumin Lee, Hojin Kim, Yunseo Ji, Byungchul Cho, Su Ssan Kim, Jinhong Jung, Jungwon Kwak, Jin-hong Park, Sang-wook Lee, Jong Hoon Kim, Sang Min Yoon
Scientific Reports.2018;[Epub] CrossRef Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
Jongmoo Park, Jinhong Jung, Daegeun Kim, In-Hye Jung, Jin-hong Park, Jong Hoon Kim, Sang-wook Lee, Sang Min Yoon
BMC Cancer.2018;[Epub] CrossRef Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification
Minjong Lee, Young Chang, Sohee Oh, Young Youn Cho, Dhong-Eun Jung, Hong Hyun Kim, Joon Yeul Nam, Hyeki Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Nam-Joon Yi, Kwang-Woong Lee, Dong Ho Lee, Jeong Min Lee, Jung-Hwan Yoon, Kyung-Suk Suh, Yoon Jun Kim
Gut and Liver.2018; 12(5): 571. CrossRef A new scoring model predicting macroscopic vascular invasion of early-intermediate hepatocellular carcinoma
Yao Liu, Le Sun, Fangyuan Gao, Xue Yang, Yuxin Li, Qun Zhang, Bingbing Zhu, Shuaishuai Niu, Yunyi Huang, Ying Hu, Ying Feng, Yuyong Jiang, Xianbo Wang
Medicine.2018; 97(49): e13536. CrossRef Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: Current status and future
Min Woo Lee, Hyo Keun Lim
World Journal of Gastroenterology.2018; 24(46): 5215. CrossRef Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis
Guo Tian, Shigui Yang, Jinqiu Yuan, Diane Threapleton, Qiyu Zhao, Fen Chen, Hongcui Cao, Tian’an Jiang, Lanjuan Li
BMJ Open.2018; 8(10): e021269. CrossRef MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2
Guannan Wang, Xiaosan Fang, Meng Han, Xiaoming Wang, Qiang Huang
International Journal of Molecular Medicine.2018;[Epub] CrossRef The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cells
Huihui Li, Yichang Fan, Fan Yang, Lei Zhao, Bangwei Cao
Oncology Letters.2018;[Epub] CrossRef Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013–2015
Monica L. Kasting, Anna R. Giuliano, Richard R. Reich, Richard G. Roetzheim, David R. Nelson, Elizabeth Shenkman, Susan T. Vadaparampil
Cancer Epidemiology, Biomarkers & Prevention.2018; 27(4): 503. CrossRef Hepatocellular Carcinoma Surveillance: Benefit of Serum Alfa-fetoprotein in Real-world Practice
Patharapan Lersritwimanmaen, Supot Nimanong
Euroasian Journal of Hepato-Gastroenterology.2018; 8(1): 83. CrossRef Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area
Jung Ho Im, Sang Min Yoon, Hee Chul Park, Jong Hoon Kim, Jeong Il Yu, Tae Hyun Kim, Jun Won Kim, Taek‐Keun Nam, Kyubo Kim, Hong Seok Jang, Jin Hee Kim, Mi‐Sook Kim, Won Sup Yoon, Inkyung Jung, Jinsil Seong
Liver International.2017; 37(1): 90. CrossRef Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver
Hyo Jung Cho, Bohyun Kim, Jung-Dong Lee, Dae Ryong Kang, Jai Keun Kim, Jei Hee Lee, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Kwang Jae Lee, Soon Sun Kim, Jae Youn Cheong, Sung Won Cho
American Journal of Gastroenterology.2017; 112(3): 460. CrossRef Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment
Hyo Jung Cho, Soon Sun Kim, Ji Sun Nam, Jai Keun Kim, Jei Hee Lee, Bohyun Kim, Hee Jung Wang, Bong Wan Kim, Jung-Dong Lee, Dae Yong Kang, Ji Hyun Kim, Yang Min Jae, Jae Chul Hwang, Sung Jae Shin, Kee Myung Lee, Sung Won Cho, Jae Youn Cheong
Clinics and Research in Hepatology and Gastroenterology.2017; 41(2): 181. CrossRef Development and application of micro-polysaccharide drug carriers incorporating doxorubicin and superparamagnetic iron oxide for bimodality treatment of hepatocellular carcinoma
Sung-Ling Tang, Meng-Yi Bai, Jyun-Yi Wang, Po-Da Hong
Colloids and Surfaces B: Biointerfaces.2017; 151: 304. CrossRef Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis
Jeong Eun Yoo, Young-Joo Kim, Hyungjin Rhee, Haeryoung Kim, Ei Yong Ahn, Jin Sub Choi, Massimo Roncalli, Young Nyun Park, Taro Yamashita
PLOS ONE.2017; 12(1): e0170465. CrossRef Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area
Dong Hyeon Lee, Jeong-Hoon Lee, Yong Jin Jung, Jungsoo Gim, Won Kim, Byeong Gwan Kim, Kook Lae Lee, Yuri Cho, Jeong-Ju Yoo, Minjong Lee, Young Youn Cho, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Sheng-Nan Lu
PLOS ONE.2017; 12(1): e0170394. CrossRef Three-dimensional (3D) printing of mouse primary hepatocytes to generate 3D hepatic structure
Yohan Kim, Kyojin Kang, Jaemin Jeong, Seung Sam Paik, Ji Sook Kim, Su A Park, Wan Doo Kim, Jisun Park, Dongho Choi
Annals of Surgical Treatment and Research.2017; 92(2): 67. CrossRef The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
Jung Hee Kim, Dong Hyun Sinn, Sung Wook Shin, Sung Ki Cho, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi
Clinical and Molecular Hepatology.2017; 23(1): 42. CrossRef Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133
Wonhee Hur, Jae Yong Ryu, Hyun Uk Kim, Sung Woo Hong, Eun Byul Lee, Sang Yup Lee, Seung Kew Yoon
Scientific Reports.2017;[Epub] CrossRef Comparison of laparoscopic liver resection for lesions located in anterolateral and posterosuperior segments: a meta-analysis
Benbo Zheng, Rongce Zhao, Xiaodong Li, Bo Li
Surgical Endoscopy.2017; 31(11): 4641. CrossRef A model predicting survival of patients with recurrent or progressive hepatocellular carcinoma: the MORE score
Sang Il Choi, Ami Yu, Bo Hyun Kim, Eun Jeong Ko, Soon Seob Park, Byung‐Ho Nam, Joong‐Won Park
Journal of Gastroenterology and Hepatology.2017; 32(3): 651. CrossRef 3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
Minjong Lee, Ara Jo, Seulki Lee, Jong Bin Kim, Young Chang, Joon Yeul Nam, Hyeki Cho, Young Youn Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim, Yuan-Soon Ho
PLOS ONE.2017; 12(3): e0174271. CrossRef Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience over 10 years
J.G. Park, S.Y. Park, W.Y. Tak, Y.O. Kweon, S.Y. Jang, Y.R. Lee, K. Hur, H.J. Lee, H.W. Lee
Clinical Radiology.2017; 72(8): 692.e9. CrossRef Letter to the Editor, Re: Cadier et al. (2017)
Chibuzo Iloabuchi, Amanda Stover, Pragya Rai, Yifan Zhang, Khalid M. Kamal
Hepatology.2017; 66(1): 299. CrossRef Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma
Shin Ok Jeong, Eui Bae Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Sang Gyune Kim, Sang Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim, Dong Erk Goo, Su Yeon Park
Gut and Liver.2017; 11(3): 409. CrossRef Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma
Suk-Won Suh, Yoo Shin Choi
Yonsei Medical Journal.2017; 58(4): 737. CrossRef Safety and Efficacy of Transarterial Radioembolisation in Patients with Intermediate or Advanced Stage Hepatocellular Carcinoma Refractory to Chemoembolisation
Elisabeth G. Klompenhouwer, Raphaëla C. Dresen, Chris Verslype, Annouschka Laenen, Gert De Hertogh, Christophe M. Deroose, Lawrence Bonne, Vincent Vandevaveye, Geert Maleux
CardioVascular and Interventional Radiology.2017; 40(12): 1882. CrossRef Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma
Binghua Li, Wendu Feng, Ouyang Luo, Tiancheng Xu, Yajuan Cao, Hongyan Wu, Decai Yu, Yitao Ding
Scientific Reports.2017;[Epub] CrossRef Differential significance of early surgical complications for acute and long-term recurrence-free survival following surgical resection of hepatocellular carcinoma: do comorbidities play a role?
Andrej Khandoga, Moritz Drefs, Markus Schoenberg, Tobias Schiergens, Katharina Frenes, Mark op den Winkel, Christoph Trumm, Martin K. Angele, Markus Guba, Jens Werner, Markus Rentsch
European Journal of Gastroenterology & Hepatology.2017; 29(9): 1045. CrossRef Percutaneous Dual-Switching Monopolar Radiofrequency Ablation Using a Separable Clustered Electrode: A Preliminary Study
Tae Won Choi, Jeong Min Lee, Dong Ho Lee, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Joon Koo Han
Korean Journal of Radiology.2017; 18(5): 799. CrossRef Peritumoral decreased uptake area of gadoxetic acid enhanced magnetic resonance imaging and tumor recurrence after surgical resection in hepatocellular carcinoma
Seung Kak Shin, Yun Soo Kim, Young Sup Shim, Seung Joon Choi, So Hyun Park, Dong Hae Jung, Oh Sang Kwon, Duck Joo Choi, Ju Hyun Kim
Medicine.2017; 96(33): e7761. CrossRef Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil versus transarterial chemoembolization using doxorubicin for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective anal
Sung Won Lee, Hae Lim Lee, Nam Ik Han, Jung Hyun Kwon, Soon Woo Nam, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Therapeutic Advances in Medical Oncology.2017; 9(10): 615. CrossRef Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma
Jennifer Eatrides, Emilie Wang, Nishi Kothari, Richard Kim
Cancer Control.2017; 24(3): 107327481772924. CrossRef Refining the management of patients with hepatocellular carcinoma integrating 11C-choline PET/CT scan into the multidisciplinary team discussion
Ezio Lanza, Matteo Donadon, Paolo Felisaz, Antonio Mimmo, Arturo Chiti, Guido Torzilli, Luca Balzarini, Egesta Lopci
Nuclear Medicine Communications.2017; 38(10): 826. CrossRef Liver Function Assessment Using Albumin–Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation
In Soo Oh, Dong Hyun Sinn, Tae Wook Kang, Min Woo Lee, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Digestive Diseases and Sciences.2017; 62(11): 3235. CrossRef Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma
Pegah Golabi, Thomas Jeffers, Zahra Younoszai, Munkhzul Otgonsuren, Mehmet Sayiner, Alita Mishra, Chapy Venkatesan, Zobair M. Younossi
Annals of Hepatology.2017; 16(4): 555. CrossRef Development of a nomogram for screening of hepatitis B virus-associated hepatocellular carcinoma
Jung Wha Chung, Eun Sun Jang, Jaihwan Kim, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Kyung Ho Lee, Jin-Wook Kim
Oncotarget.2017; 8(63): 106499. CrossRef Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results
Sun Hyun Bae, Won Il Jang, Hee Chul Park
Oncotarget.2017; 8(35): 59965. CrossRef High-dose radiotherapy is associated with better local control of bone metastasis from hepatocellular carcinoma
In-Hye Jung, Sang Min Yoon, Jungwon Kwak, Jin-Hong Park, Si Yeol Song, Sang-Wook Lee, Seung Do Ahn, Eun Kyung Choi, Jong Hoon Kim
Oncotarget.2017; 8(9): 15182. CrossRef Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria
Yuri Cho, Jeong-Hoon Lee, Dong Hyeon Lee, Eun Ju Cho, Su Jong Yu, Nam-Joon Yi, Kwang-Woong Lee, Yoon Jun Kim, Jung-Hwan Yoon, Kyung-Suk Suh
Oncotarget.2017; 8(29): 47555. CrossRef Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study
Ji Hae Nahm, Hyungjin Rhee, Haeryoung Kim, Jeong Eun Yoo, Jee San Lee, Youngsic Jeon, Gi Hong Choi, Young Nyun Park
Oncotarget.2017; 8(59): 99359. CrossRef Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy
In Rae Cho, Hye Won Lee, Ki Jun Song, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Jinsil Seong, Kwang-Hyub Han, Jun Yong Park
Oncotarget.2017; 8(45): 79914. CrossRef Hepatocellular carcinoma: Implications for Asia-Pacific Oncology Nurses
Deborah A Boyle
Asia-Pacific Journal of Oncology Nursing.2017; 4(2): 98. CrossRef Comparison of laparoscopic liver resection for hepatocellular carcinoma located in the posterosuperior segments or anterolateral segments: A case-matched analysis
Woohyung Lee, Ho-Seong Han, Yoo-Seok Yoon, Jai Young Cho, YoungRok Choi, Hong Kyung Shin, Jae Yool Jang, Hanlim Choi, Jae Seong Jang, Seong Uk Kwon
Surgery.2016; 160(5): 1219. CrossRef Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells
Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Chung Yong Kim, Jung-Hwan Yoon
Biomedicine & Pharmacotherapy.2016; 83: 607. CrossRef Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma
Young-Hsiang Lin, Shih-Kai Hung, Wen-Yen Chiou, Moon-Sing Lee, Bing-Jie Shen, Liang-Cheng Chen, Dai-Wei Liu, Wei-Ta Tsai, Po-Hao Lin, Yi-Ting Shih, Feng-Chun Hsu, Shiang-Jiun Tsai, Michael W.Y. Chan, Hon-Yi Lin
Medicine.2016; 95(34): e4717. CrossRef Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria
Jung Hee Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Ki Yeon Kim, Kyunga Kim, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Medicine.2016; 95(35): e4735. CrossRef Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B
Yuri Cho, Dong Hyun Sinn, Su Jong Yu, Geum Youn Gwak, Ji Hoon Kim, Yang Jae Yoo, Dae Won Jun, Tae Yeob Kim, Hyo Young Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon, Sheng-Nan Lu
PLOS ONE.2016; 11(11): e0165722. CrossRef
|